Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene

[1]  Y. Ni,et al.  A Novel Heterozygous NF1 Variant in a Neurofibromatosis-Noonan Syndrome Patient with Growth Hormone Deficiency: A Case Report , 2022, Journal of clinical research in pediatric endocrinology.

[2]  M. Zenker,et al.  Noonan syndrome: improving recognition and diagnosis , 2022, Archives of Disease in Childhood.

[3]  R. Capșa,et al.  Neurofibromatosis 1-Noonan Syndrome Associated with Pulmonary Stenosis and Hypertrophic Cardiomyopathy , 2021 .

[4]  C. Wolf,et al.  European Medical Education Initiative on Noonan syndrome: A clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe. , 2021, European journal of medical genetics.

[5]  G. Fekete,et al.  Diagnostic difficulties and possibilities of NF1-like syndromes in childhood , 2021, BMC Pediatrics.

[6]  H. Martelli Júnior,et al.  Cafe-au-lait spots as a clinical sign of syndromes , 2021, Research, Society and Development.

[7]  K. Hunt,et al.  Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020 , 2021, JAMA network open.

[8]  M. Ramón-Krauel,et al.  [Noonan syndrome: genetic and clinical update and treatment options]. , 2020, Anales de pediatria.

[9]  Zhen Zhang,et al.  Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1–58 deletion: a case report , 2020, BMC Pediatrics.

[10]  T. Atik,et al.  A Neurofibromatosis Noonan Syndrome Patient Presenting with Abnormal External Genitalia , 2020, Journal of clinical research in pediatric endocrinology.

[11]  M. Maleki,et al.  Genotypic effect of a mutation of the MYBPC3 gene and two phenotypes with different patterns of inheritance , 2018, Journal of clinical laboratory analysis.

[12]  H. Cavé,et al.  Genotype and phenotype spectrum of NRAS germline variants , 2017, European Journal of Human Genetics.

[13]  M. Maleki,et al.  MYO15A splicing mutations in hearing loss: A review literature and report of a novel mutation. , 2017, International journal of pediatric otorhinolaryngology.

[14]  D. Tester,et al.  Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy. , 2016, JCI insight.

[15]  D. Vidaud,et al.  Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome , 2016, Journal of clinical research in pediatric endocrinology.

[16]  Yoichi Matsubara,et al.  Recent advances in RASopathies , 2015, Journal of Human Genetics.

[17]  M. Summar,et al.  Malignancy in Noonan syndrome and related disorders , 2015, Clinical genetics.

[18]  Ying Liu,et al.  High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype Correlation , 2015, Human mutation.

[19]  R. Ferner,et al.  Neurofibromatosis-related tumors: emerging biology and therapies , 2015, Current opinion in pediatrics.

[20]  Philippe M. Campeau,et al.  Genotype-Phenotype Correlation , 2014 .

[21]  John D McPherson,et al.  Next-generation sequencing identifies rare variants associated with Noonan syndrome , 2014, Proceedings of the National Academy of Sciences.

[22]  W. Mason.  THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES , 2014 .

[23]  S. Huson,et al.  Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype–phenotype correlation , 2012, European Journal of Human Genetics.

[24]  Y. Zhang,et al.  A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality. , 2012, Genetics and molecular research : GMR.

[25]  S. Ekvall,et al.  Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1 , 2009, Clinical genetics.

[26]  M. Digilio,et al.  Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum , 2009, Human mutation.

[27]  Yoichi Matsubara,et al.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome , 2007, Journal of Medical Genetics.

[28]  D. Stevenson,et al.  Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype , 2006, Clinical genetics.

[29]  Kam Y. J. Zhang,et al.  Germline KRAS mutations cause Noonan syndrome , 2006, Nature Genetics.

[30]  L. Radfar,et al.  A case of neurofibromatosis-Noonan syndrome with a central giant cell granuloma. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[31]  Ş. Ayter,et al.  Neurofibromatosis—Noonan's Syndrome With Associated Rhabdomyosarcoma of the Urinary Bladder in an Infant: Case Report , 2003, Journal of child neurology.

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  Bruce D Gelb,et al.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. , 2002, American journal of human genetics.

[34]  J. Friedman,et al.  Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children , 2000, Neurology.

[35]  A. Sommer,et al.  Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia: a report of two cases. , 1999, Journal of pediatric hematology/oncology.

[36]  J. Opitz,et al.  Noonan phenotype associated with neurofibromatosis. , 1985, American journal of medical genetics.

[37]  G D'Hont,et al.  [The Noonan syndrome]. , 1982, Acta oto-rhino-laryngologica Belgica.